UBS O'Connor’s Enphys Acquisition Corp. NFYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-122,826
Closed -$1.35M 651
2024
Q2
$1.35M Hold
122,826
0.04% 255
2024
Q1
$1.33M Hold
122,826
0.04% 244
2023
Q4
$1.31M Sell
122,826
-55,207
-31% -$585K 0.04% 238
2023
Q3
$1.87M Hold
178,033
0.03% 255
2023
Q2
$1.85M Sell
178,033
-4,013
-2% -$41.3K 0.04% 312
2023
Q1
$1.86M Hold
182,046
0.04% 335
2022
Q4
$1.83M Sell
182,046
-1,781
-1% -$17.6K 0.03% 484
2022
Q3
$1.79M Sell
183,827
-18,403
-9% -$179K 0.02% 656
2022
Q2
$1.95M Buy
+202,230
New +$1.95M 0.02% 662

Other funds holding NFYS

UBS O'Connor's NFYS Position: Q3 2024 in Review

UBS O'Connor sold out of Enphys Acquisition Corp. (NFYS) in Q3 2024, closing a stake of 122,826 shares — an estimated $1.35M sold.

UBS O'Connor first reported a position in NFYS in Q2 2022 and held it in 9 quarters. The position peaked at $1.95M in Q2 2022. 5 funds tracked by Wall St. Rank hold NFYS as of Q3 2024.

  • UBS O'Connor reported no remaining Enphys Acquisition Corp. position as of Q3 2024 after selling out during the quarter.
  • UBS O'Connor sold 122,826 Enphys Acquisition Corp. shares in Q3 2024, an estimated $1.35M.
  • UBS O'Connor first reported a position in Enphys Acquisition Corp. in Q2 2022 and held it in 9 quarters.
  • UBS O'Connor's Enphys Acquisition Corp. position peaked at $1.95M in Q2 2022.
  • 5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. as of Q3 2024.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.